Peer Review History

Original SubmissionJuly 29, 2024
Decision Letter - Sepiso K. Masenga, Editor

PONE-D-24-30787Alterations in the inflammatory markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents.PLOS ONE

Dear Dr. RIBEIRO,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please attend to the comments from reviewer 2 as suggested.

==============================

Please submit your revised manuscript by Nov 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Sepiso K. Masenga, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in your Competing Interests section: 

“The authors have no conflicts of interest to declare.”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

3. We note that your Data Availability Statement is currently as follows: [If the data are all contained within the manuscript and/or Supporting Information files, enter the following: All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories .

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Title: Alterations in the Inflammatory Markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents

Summary

This study by Palhares et. al investigates the relationship between obesity, inflammation, and metabolic markers in children, predominantly focusing on TNF-α and soluble TRAIL (sTRAIL). Though the study was unable to detect TNF-α in most samples, it reveals significant differences in metabolic markers between obese and non-obese children. Study findings suggest that inflammation plays a role in childhood obesity, though the precise mechanisms remain unclear. The present study highlights the need for more studies to determine sTRAIL’s role in obesity-related complications.

Comment

The article is well-written and presents a clear and focused investigation into the relationship between obesity, inflammation, and metabolic markers in children and adolescents. The authors have effectively explained the study's objectives, methods, and findings on obesity-related inflammation. Despite limitations, the study addresses important gaps in pediatric obesity research and suggests avenues for future exploration, particularly regarding inflammatory markers. The language is accessible, and the structure is logical, making the article a valuable contribution to the field.

Based on its scientific merit and clarity, the article deserves to be considered for publication.

Reviewer #2: Manuscript title: Alterations in the inflammatory markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents.

Summary statement of the article

The article titled "Alterations in the Inflammatory Markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents." This study explores the relationship between cardio-metabolic risk markers and the Tumor Necrosis Factor system in a diverse group of children and adolescents. In the study, authors analyzed various clinical and laboratory parameters to better understand the impact of overweight and obesity on inflammatory markers. The research aims to provide insights into the inflammatory responses linked to obesity in the pediatric population, contributing to a better understanding of the health implications of childhood obesity. The manuscript title and in itself is a scientific marvel to look at. However, some things can be looked at to improve the article.

Specific areas of improvement

Major comments:

1. Under materials and methods, lines 120-139 are a bit confusing with the grammar. Follow the heading and revise accordingly the entire section. I must the criteria of participant selection is confusing and given slim chances that it can replicated.

2. From Table 1, under the results section you have indicated 2 groups of interest contrary to the concept of 3 groups. Please indicate the characteristics of the eutrophic group as well.

3. Include the subheadings where necessary, it is not easy to tell which paragraph has clinical implications, conclusion/summary including the limitations of the study which could be expanded.

4. Results have not been clearly communicated, the discussion has the comparison factor to other relevant literature which the majority has been cited but the logic flow is a bit missing.

Minor comments:

1. Lines 184-188, “The project was approved by the Committee of Ethics in Research with Human Beings of UFTM (protocol no. 2479). Children, adolescents and parents and/or parents were clarified about the research project and those who agreed to participate of the study project signed the term of free and informed consent and the term of assent.” Move text to somewhere under statements of ethics and revise the sentence.

2. Spelling error I guess of “Eutrofic” in Figure 1. Please clarify.

3. Overall the grammar in the article is not so clear to easily understand, if authors can logically simplify the text and also there are some short paragraphs which can be merged into sizeable pieces, that would be great and could improve the clarity of the article.

4. Cite each statement that has been made in the article, as this covers authors on plagiarism. E.g. lines 67-71, 83-85. Please countercheck for others.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Response to reviewers:

Manuscript title: Alterations in the inflammatory markers of the Tumor Necrosis Factor system in overweight and obese children and adolescents.

Larger comments:

Major comments:

1. Under materials and methods, lines 120-139 are a bit confusing with the grammar. Follow the heading and revise accordingly the entire section. I must the criteria of participant selection is confusing and given slim chances that it can replicated:

Response: In materials and methods, grammar was revised and the article was sent to Wiley Editing Services, as you can see in the certificate that we attached in the supplementary materials. The changes made are marked in the revised text.

Lines 129-139 were written as follows:

From February 2013 to July 2014, 172 children (5 to 9 years) and adolescents (10 to 19 years old) who were overweight and obese attended the consultation. All children and adolescents who consulted at the UFTM outpatient clinic were examined by the same doctor, submitted to the collection of pertinent laboratory tests, nutritional guidance provided by a nutritionist and drug treatment when necessary. During the consultation, they were invited to participate in the research project, with refusal by the same or responsible in 10 cases and exclusion from the study in 1 case due to the diagnosis of Osteogenesis Imperfecta. Thus, the final sample consisted of 161 overweight and obese children and adolescents. The eutrophic group consisted of 40 children and adolescents. A cross-sectional study was carried out.

Now the lines are written as follows:

A previous study was carried out in the city of Uberaba, Minas Gerais, Brazil from March 2012 to September 2013, where 1,125 school children and adolescents (5 to 19 years of age) were evaluated, where 916 were from public schools and 209 were from private schools; 364 participants had inadequate body weight, while 195 were overweight (17%) and 169 were obese (15%) [24].

The study participants were invited to attend the Triangulo Mineiro Federal University (UFTM) Pediatric Endocrinology Outpatient Clinic, to carry out medical consultations, laboratory tests, and receive guidance on the treatment of excess weight.

However, only 172 children (5 to 9 years) and adolescents (10 to 19 years old) attended the consultation. All 172 participants were examined by the same doctor, submitted to the collection of pertinent laboratory tests, and nutritional guidance was provided by a nutritionist along with drug treatment when necessary. During the consultation, they were invited to participate in the research project conducted from February 2013 to July 2014. Ten participants refused to participate, and we excluded one case due to the diagnosis of Osteogenesis Imperfecta. Thus, the final sample consisted of 161 overweight and obese children and adolescents. The eutrophic group consisted of 40 children and adolescents. A cross-sectional study was carried out.

2. From Table 1, under the results section you have indicated 2 groups of interest contrary to the concept of 3 groups. Please indicate the characteristics of the eutrophic group as well:

Response: Table 1, results section, was revised and we added the group of eutrophic patients as requested.

3. Include the subheadings where necessary, it is not easy to tell which paragraph has clinical implications, conclusion/summary including the limitations of the study which could be expanded:

Response: We reviewed the grammar and translation of the study to better understanding of all sections of the article. We saw no need to include subtitles.

4. Results have not been clearly communicated, the discussion has the comparison factor to other relevant literature which the majority has been cited but the logic flow is a bit missing:

Response: The discussion flow has been revised and we have added pertinent relevant literature.

Minor comments:

1. Lines 184-188, “The project was approved by the Committee of Ethics in Research with Human Beings of UFTM (protocol no. 2479). Children, adolescents and parents and/or parents were clarified about the research project and those who agreed to participate of the study project signed the term of free and informed consent and the term of assent.” Move text to somewhere under statements of ethics and revise the sentence.

Response: The text was moved to a place about ethics statement. However, one of the guidelines received in this email was that the ethics statement should only appear in the materials and methods section. Therefore, this guidance was a little contradictory because, in the guidance sent, it asks for this phrase to appear only in the methods section and in the reviewer's comments it asks for it to appear in an appropriate place.

2. Spelling error I guess of “Eutrofic” in Figure 1. Please clarify.

Response: Spelling error of the word eutrophic was corrected.

3. Overall the grammar in the article is not so clear to easily understand, if authors can logically simplify the text and also there are some short paragraphs which can be merged into sizeable pieces, that would be great and could improve the clarity of the article.

Response: Spelling and translation into English have been revised

4. Cite each statement that has been made in the article, as this covers authors on plagiarism. E.g. lines 67-71, 83-85. Please countercheck for others.

Response: A review of the article's references was carried out, the lines oriented for review are based on references 1; 2 e 12 that were added.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Sepiso K. Masenga, Editor

Alterações nos marcadores inflamatórios do sistema Fator de Necrose Tumoral em crianças e adolescentes com sobrepeso e obesidade.

PONE-D-24-30787R1

Dear Dr. RIBEIRO,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sepiso K. Masenga, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The authors have rigorously addressed the submitted review comments, resolving concerns to enhance the manuscript's clarity.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Sepiso K. Masenga, Editor

PONE-D-24-30787R1

PLOS ONE

Dear Dr. Ribeiro,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Sepiso K. Masenga

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .